The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
This report finds the public is generally supportive of U.S. distribution of vaccines internationally, though more likely to prefer the U.S. playing a major role versus a leading one, and there are partisan differences. The analysis also examines how different information affects the public's views.
In this Axios column, Drew Altman examines the data about what parents say they will do once their children ages 5-11 become eligible for a COVID-19 vaccine, and why it will take some time and a concerted outreach effort to match adult vaccination rates.
This report tracks the public's COVID-19 vaccine intentions, including parents' intentions for their children ages 5-11 who may soon become eligible to get a vaccine. It also examines workers' experiences with and views toward employer vaccine mandates and the public's holiday plans heading into the second holiday season under the pandemic.
Most Parents Say Their Kids Will Go Trick-or-Treating for Halloween; 1 in 8 Won’t Due to COVID-19 With the Biden administration moving to require large employers to require COVID-19 vaccinations and require weekly testing for unvaccinated workers, the latest KFF COVID-19 Vaccine Monitor report finds a quarter (25%) of workers say their employer has a…
Increasing availability of high-quality comprehensive data disaggregated by race/ethnicity is a prerequisite for efforts to advance health equity, not only related to COVID-19 but in health and health care more broadly.
A new KFF issue brief lays out key factors for the successful rollout of COVID-19 vaccinations for younger children, ages 5 to 11. This week, the Food and Drug Administration’s (FDA) advisory committee will meet to vote on a request to authorize the Pfizer vaccine for younger children.
This brief highlights key issues to consider for the vaccination rollout to younger children.
To better understand the extent to which states have adopted policies consistent with CDC guidance, we examined state policies for all 50 states and DC focused on COVID-19 prevention strategies in K-12 public schools for the 2021-2022 school year.
In this Axios column, Drew Altman takes on the idea that communities of color are behind the problem of the unvaccinated in the U.S.
While the federal, state, and survey data all show narrowing racial disparities in COVID-19 vaccination rates over time, they vary in the magnitude of this narrowing, with some surveys showing that gaps have closed, while the administrative data pointing to some remaining differences. This variation in findings reflects both differences and limitations across the datasets.
© 2025 KFF